These characteristics of [11C]UCB‐J therefore permit its use as an in vivo marker for synaptic loss in frontotemporal dementia, irrespective of whether the underlying pathology is tau or TDP‐43. This evidence concerns the gene MAPT and frontotemporal dementia.